Kestra Medical Technologies, Ltd. (KMTS) Reports Q3 Loss of $0.50, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts KMTS Hot Sheet
Join SI Premium – FREE
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q3 EPS of ($0.50). Revenue for the quarter came in at $19.4 million.
Fiscal Year 2026 Revenue Guidance
Kestra is increasing its FY26 revenue guidance to $88 million, representing growth of 47% compared to FY25. This compares to prior FY26 revenue guidance of $85 million.
For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- BMO Capital Upgrades IGM Financial Inc (IGM:CN) (IGIFF) to Outperform
- JPMorgan Upgrades Ageas (AGS:BB) (AGESY) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
